New building project : oncology and hematology excellence around the patient

The Cliniques universitaires Saint-Luc are grouping their cancer and haematology activities in a new institute: the King Albert II Institute. The construction of this 20,000 m² building on the UCL campus started in early 2022.

Discover the future building in the video below

Performance results above the national average

0%

The relative survival rate of breast cancer patients, 5 years after diagnosis, all stages combined, is 91% at Saint-Luc, 5% higher than the national average.

0%

The observed survival rate of patients with cancer of the head and neck area (larynx, oropharynx, oral cavity and hypopharynx), 5 years after diagnosis, all stages combined, is 56.3% at Saint-Luc compared to 49.3% for the average institution.

0%

The relative survival rate of rectal cancer patients treated at IRA II is 78.7% compared to 66.2% for the average Belgian institution.